BackRBC Life Sciences Overview

RBC Life Sciences Accounts Payable

Track RBC Life Sciences's accounts payable ($3.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$3.46M
↑ 82.50% YoYΔ $1.57M vs prior year quarter

Peer trimmed avg / median

Loading

RBC Life Sciences Accounts Payable History

Loading

RBC Life Sciences vs. peers: Accounts Payable Comparison

Loading

RBC Life Sciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

RBC Life Sciences (RBCL) FAQ

RBC Life Sciences (RBCL) currently reports a accounts payable of $3.5M as of September 2017. That compares with $1.9M in the prior-year period — up 82.5% year over year. Use the charts on this page to explore RBC Life Sciences's accounts payable history and peer comparisons.

RBC Life Sciences's accounts payable increased from $1.9M to $3.5M — a 82.5% year-over-year increase (period ending September 2017). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RBC Life Sciences reported $3.5M in accounts payable as of September 2017. That compares with $1.9M in the prior-year period — up 82.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $3.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for RBC Life Sciences, and consider following RBCL for alerts when major investors trade the stock.